Litigation Details for ARBUTUS PHARMA CORP. v. PFIZER INC. (D.N.J. 2023)
✉ Email this page to a colleague
ARBUTUS PHARMA CORP. v. PFIZER INC. (D.N.J. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-04-04 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 28:1338 Patent Infringement | Assigned To | Zahid Nisar Quraishi |
| Jury Demand | Both | Referred To | Tonianne J. Bongiovanni |
| Patents | 8,058,069; 8,492,359; 8,822,668; 9,364,435 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ARBUTUS PHARMA CORP. v. PFIZER INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ARBUTUS PHARMA CORP. v. PFIZER INC. (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-04-04 | 1 | Complaint | November 29, 2016 (the “’651 Patent”). b. U.S. Patent No. 8,492,359, “Lipid Formulations for…infringement of the ’651 Patent. COUNT 2: INFRINGEMENT OF U.S. PATENT NO. 8,492,359 80. … acid-based medicines: U.S. Patent Nos. 9,504,651 (Exhibit A); 8,492,359 (Exhibit B); 11,141,378 (Exhibit… them. Among those patents are the Asserted Patents: a. U.S. Patent No. 9,504,651, “Lipid…’320 Patent under 35 U.S.C. § 271(a) by using the patented apparatus covered by the ’320 Patent to make | External link to document |
| 2024-07-11 | 101 | Redacted Document | 15, 2008 provisional application: U.S. Patent Nos.: 8,058,069, 8,822,668, and 9,364,435. Case 3:23-cv…success of Comirnaty®, asserting five patents (across two patent families that date back to 2002 and …Comirnaty® infringes those asserted patents. The asserted patents, however, do not claim the specific …attempt by Plaintiffs to leverage the patents-in-suit (or patent family members thereof) into an unearned… of the same patents-in-suit, as well as three additional family members to the patents-in-suit.2 Each | External link to document |
| 2024-07-11 | 102 | Redacted Document | a single excerpt of a claim from U.S. Patent No. 8,492,359 asserted in this case, both excerpts referring…Plaintiffs emphasize each patent’s generic reference to mRNA, and each patent claim’s recitation of “an…Alnylam) is asserting its own patents that are unrelated to the patents in this case. Plaintiffs’ request…this case patents purporting to relate to the discovery of a new lipid ingredient. The patents at issue…claim from just one of the six patents asserted in Alnylam (U.S. Patent 11,382,979), comparing it to a | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
